JG
FMI

Joel Greenblatt’s Foundation Medicine, Inc. FMI Stock Holding History

Joel Greenblatt’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-9,384
Closed -$451K – 1098
2015
Q1 		$451K Buy
+9,384
New +$426K ﹤0.01% 721

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return

Joel Greenblatt's FMI Position: Q2 2015 in Review

Joel Greenblatt sold out of Foundation Medicine, Inc. (FMI) in Q2 2015, closing a stake of 9,384 shares — an estimated $451K sold.

Joel Greenblatt first reported a position in FMI in Q1 2015 and held it in 1 quarter. The position peaked at $451K in Q1 2015. 96 funds tracked by Wall St. Rank hold FMI as of Q2 2015.

  • Joel Greenblatt reported no remaining Foundation Medicine, Inc. position as of Q2 2015 after selling out during the quarter.
  • Joel Greenblatt sold 9,384 Foundation Medicine, Inc. shares in Q2 2015, an estimated $451K.
  • Joel Greenblatt first reported a position in Foundation Medicine, Inc. in Q1 2015 and held it in 1 quarter.
  • Joel Greenblatt's Foundation Medicine, Inc. position peaked at $451K in Q1 2015.
  • 96 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q2 2015.

Based on Gotham Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.